NL174349C - Werkwijze voor de bereiding van derivaten van 2-amino-1-pyridylethanol en werkwijze voor de bereiding van preparaten die ze bevatten. - Google Patents
Werkwijze voor de bereiding van derivaten van 2-amino-1-pyridylethanol en werkwijze voor de bereiding van preparaten die ze bevatten.Info
- Publication number
- NL174349C NL174349C NLAANVRAGE7201471,A NL7201471A NL174349C NL 174349 C NL174349 C NL 174349C NL 7201471 A NL7201471 A NL 7201471A NL 174349 C NL174349 C NL 174349C
- Authority
- NL
- Netherlands
- Prior art keywords
- preparing
- pyridylethanol
- amino
- preparations containing
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/58—Radicals substituted by nitrogen atoms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11587871A | 1971-02-16 | 1971-02-16 | |
| US25664172A | 1972-05-25 | 1972-05-25 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NL7201471A NL7201471A (nl) | 1972-08-18 |
| NL174349B NL174349B (nl) | 1984-01-02 |
| NL174349C true NL174349C (nl) | 1984-06-01 |
Family
ID=26813670
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NLAANVRAGE7201471,A NL174349C (nl) | 1971-02-16 | 1972-02-04 | Werkwijze voor de bereiding van derivaten van 2-amino-1-pyridylethanol en werkwijze voor de bereiding van preparaten die ze bevatten. |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US3700681A (nl) |
| AT (1) | AT315842B (nl) |
| BE (1) | BE778771A (nl) |
| CA (1) | CA978962A (nl) |
| CH (1) | CH541560A (nl) |
| DE (2) | DE2204195C2 (nl) |
| FR (1) | FR2125309B1 (nl) |
| GB (2) | GB1367668A (nl) |
| NL (1) | NL174349C (nl) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR207639A1 (es) * | 1973-12-26 | 1976-10-22 | Pfizer | Un procedimiento para preparar pirido (3,2-d)1,3-dioxin-6-epoxietanos y compuestos intermediarios desprovistos de actividad terapeutica |
| US3952101A (en) * | 1975-04-14 | 1976-04-20 | Smithkline Corporation | α-Amino methyl-5-hydroxy-2-pyridinemethanols |
| US4011231A (en) * | 1975-10-03 | 1977-03-08 | Pfizer Inc. | 2-Phenyl-6-(1-hydroxy-2-t-butylaminoethyl)-4H-pyrido[3,2-d]-1,3-dioxin maleate and its use as an intermediate |
| SE7708307L (sv) * | 1976-08-26 | 1978-02-27 | Pfizer | Forfarande for framstellning av farmaceutiska kompositioner anvendbara sasom bronkodilatorer |
| US4175128A (en) * | 1979-01-03 | 1979-11-20 | Pfizer Inc. | Method for treating congestive heart failure |
| US4632992A (en) * | 1981-02-09 | 1986-12-30 | Pfizer Inc. | Intermediates for preparing pirbuterol and analogs |
| SU1194273A3 (ru) * | 1981-02-09 | 1985-11-23 | Пфайзер Инк (Фирма) | Способ получени пирбутерола или его аналогов |
| GB8414559D0 (en) * | 1984-06-07 | 1984-07-11 | Scras | Pyridine derivatives |
| EP0220054A3 (en) * | 1985-10-16 | 1987-12-02 | Glaxo Group Limited | Ethanolamine derivatives |
| US4601897A (en) * | 1985-11-06 | 1986-07-22 | Pfizer Inc. | Prazosin-pirbuterol combination for bronchodilation |
| WO1993000090A1 (en) * | 1991-06-26 | 1993-01-07 | Sepracor, Inc. | Methods and compositions for treating pulmonary and cardiac disorders using optically pure (+) pirbuterol |
| AU2270092A (en) * | 1991-06-26 | 1993-01-25 | Sepracor, Inc. | Methods and compositions for treating pulmonary and cardiac disorders using optically pure (-)pirbuterol |
| US7105152B1 (en) | 1991-12-18 | 2006-09-12 | 3M Innovative Properties Company | Suspension aerosol formulations |
| US7101534B1 (en) | 1991-12-18 | 2006-09-05 | 3M Innovative Properties Company | Suspension aerosol formulations |
| NZ545748A (en) * | 2003-08-29 | 2010-03-26 | Ranbaxy Lab Ltd | Isoxazoline derivatives as inhibitors of phosphodiesterase type-IV |
| US20070259874A1 (en) * | 2003-11-26 | 2007-11-08 | Palle Venkata P | Phosphodiesterase Inhibitors |
| WO2005092860A1 (en) * | 2004-03-23 | 2005-10-06 | Pfizer Limited | Compounds for the treatment of diseases |
| WO2007031838A1 (en) | 2005-09-16 | 2007-03-22 | Ranbaxy Laboratories Limited | Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors |
| RU2008119322A (ru) * | 2005-10-19 | 2009-11-27 | Рэнбакси Лабораториз Лимитед (In) | Композиции ингибиторов фосфодиэстеразы iv типа |
| US20090221664A1 (en) | 2005-10-19 | 2009-09-03 | Abhijit Ray | Pharmaceutical compositions of muscarinic receptor antagonists |
| JP5399902B2 (ja) | 2006-08-22 | 2014-01-29 | ランバクシー ラボラトリーズ リミテッド | マトリックスメタロプロテイナーゼ阻害剤 |
| CN101616901A (zh) * | 2006-09-22 | 2009-12-30 | 兰贝克赛实验室有限公司 | Iv型磷酸二酯酶的抑制剂 |
| US20100029728A1 (en) * | 2006-09-22 | 2010-02-04 | Ranbaxy Laboratories Limited | Phosphodiesterase inhibitors |
| EP1958947A1 (en) | 2007-02-15 | 2008-08-20 | Ranbaxy Laboratories Limited | Inhibitors of phosphodiesterase type 4 |
| US20110130403A1 (en) * | 2007-03-14 | 2011-06-02 | Ranbaxy Laboratories Limited | Pyrazolo [3, 4-b] pyridine derivatives as phosphodiesterase inhibitors |
| PT2124944E (pt) | 2007-03-14 | 2012-05-17 | Ranbaxy Lab Ltd | Derivados de pirazolo[3,4-b]piridina como inibidores de fosfodiesterase |
| EP2111861A1 (en) | 2008-04-21 | 2009-10-28 | Ranbaxy Laboratories Limited | Compositions of phosphodiesterase type IV inhibitors |
| EP2598493A1 (en) | 2010-07-30 | 2013-06-05 | Ranbaxy Laboratories Limited | Matrix metalloproteinase inhibitors |
| BR112013006932A2 (pt) | 2010-09-24 | 2016-07-12 | Ranbaxy Lab Ltd | composto composição farmacêutica e processo para preparar um composto |
| CN103848781B (zh) * | 2012-11-30 | 2017-06-30 | 重庆华邦制药有限公司 | 高选择性氧化二羟甲基吡啶中一个羟甲基的方法 |
| EA026562B1 (ru) | 2012-12-03 | 2017-04-28 | Пфайзер Инк. | Новые селективные модуляторы андрогенных рецепторов |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1089189A (en) * | 1964-09-23 | 1967-11-01 | Koninklijke Pharma Fab Nv | Ethers of -(2-pyridyl)benzyl alcohols |
-
1971
- 1971-02-16 US US115878A patent/US3700681A/en not_active Expired - Lifetime
- 1971-11-04 GB GB5141671A patent/GB1367668A/en not_active Expired
- 1971-11-04 GB GB3749773A patent/GB1367669A/en not_active Expired
-
1972
- 1972-01-27 AT AT63972A patent/AT315842B/de not_active IP Right Cessation
- 1972-01-29 DE DE2204195A patent/DE2204195C2/de not_active Expired
- 1972-01-29 DE DE2265581A patent/DE2265581C2/de not_active Expired
- 1972-02-01 BE BE778771A patent/BE778771A/xx not_active IP Right Cessation
- 1972-02-02 FR FR7203470A patent/FR2125309B1/fr not_active Expired
- 1972-02-03 CA CA133,875A patent/CA978962A/en not_active Expired
- 1972-02-04 CH CH164872A patent/CH541560A/fr not_active IP Right Cessation
- 1972-02-04 NL NLAANVRAGE7201471,A patent/NL174349C/nl not_active IP Right Cessation
- 1972-05-25 US US00256641A patent/US3763173A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| CA978962A (en) | 1975-12-02 |
| FR2125309A1 (nl) | 1972-09-29 |
| GB1367668A (en) | 1974-09-18 |
| US3700681A (en) | 1972-10-24 |
| CH541560A (fr) | 1973-10-31 |
| DE2265581C2 (de) | 1982-07-01 |
| FR2125309B1 (nl) | 1976-05-14 |
| DE2204195C2 (de) | 1981-11-19 |
| AT315842B (de) | 1974-06-10 |
| NL7201471A (nl) | 1972-08-18 |
| NL174349B (nl) | 1984-01-02 |
| US3763173A (en) | 1973-10-02 |
| BE778771A (fr) | 1972-08-01 |
| DE2204195A1 (de) | 1972-08-17 |
| GB1367669A (en) | 1974-09-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL174349C (nl) | Werkwijze voor de bereiding van derivaten van 2-amino-1-pyridylethanol en werkwijze voor de bereiding van preparaten die ze bevatten. | |
| NL149210B (nl) | Werkwijze voor de bereiding van poederlakpreparaten. | |
| NL7501032A (nl) | Werkwijze ter bereiding van anti-tuberkelmid- delen, alsmede farmaceutische preparaten die deze middelen bevatten. | |
| NL156404B (nl) | Werkwijze voor de bereiding van chromanderivaten. | |
| NL167963C (nl) | Werkwijze voor de bereiding van onkruid verdelgende preparaten, die thiadiazolylureumverbindingen bevatten, en werkwijze voor de bereiding van dergelijke thiadiazolylureumverbindingen. | |
| NL7514255A (nl) | Werkwijze voor de bereiding van piperidylindolen en farmaceutische preparaten die ze bevatten. | |
| NL148317B (nl) | Werkwijze voor de bereiding van benzo (b) thiofeenazijnzuurderivaten, en van preparaten die ze bevatten. | |
| NL170285C (nl) | Werkwijze voor de bereiding van verbindingen met antiallergische werking en werkwijze voor de bereiding van preparaten die ze bevatten. | |
| NL160828C (nl) | Werkwijze voor de bereiding van anti-bacteriele 7-acrylglycyl cefalosporine-derivaten en preparaten die ze bevatten. | |
| NL7514446A (nl) | Werkwijze voor de bereiding van prostaglandines en van preparaten die ze bevatten. | |
| NL175827C (nl) | Werkwijze voor het bereiden van alfa-(5-indanyloxycarbonyl)-benzylpenicilline en van farmaceutische preparaten daaruit. | |
| NL172163C (nl) | Werkwijze voor de bereiding van dinor-cholestaan-derivaten. | |
| NL176171C (nl) | Werkwijze voor de bereiding van anti-adrenerge verbindingen en voor de bereiding van preparaten die ze bevatten. | |
| NL148319B (nl) | Werkwijze voor de bereiding van herbicide verbindingen en preparaten die ze bevatten. | |
| NL7608903A (nl) | Werkwijze voor de bereiding van guanidine- -derivaten en van preparaten die ze bevatten. | |
| NL152248B (nl) | Werkwijze voor de bereiding van complexen van alfa-6-deoxy-5-hydroxytetracycline. | |
| NL167970C (nl) | Werkwijze voor het bereiden van neriifolinederivaten en van therapeutische preparaten, die dergelijke derivaten bevatten, alsmede gevormde therapeutische preparaten. | |
| NL175063C (nl) | Werkwijze ter bereiding van 11,11-alkylideensteroiden, werkwijze ter bereiding van farmaceutische preparaten en gevormde farmaceutische preparaten. | |
| NL178255C (nl) | Werkwijze voor de bereiding van aryloxypropylpiperazine-derivaten, met deze werkwijze gevormde voortbrengselen en werkwijze voor de bereiding van preparaten die ze bevatten. | |
| NL162902C (nl) | Werkwijze voor de bereiding van oxaprostaglandien- -analoga en voor de bereiding van farmaceutische prepa- raten die ze bevatten. | |
| NL150457B (nl) | Werkwijze voor de bereiding van bactericide stoffen en preparaten. | |
| NL7605385A (nl) | Werkwijze voor de bereiding van 3-nitropyrazool- -derivaten en van preparaten die ze bevatten. | |
| NL168497B (nl) | Werkwijze voor de bereiding van 2-(o-anilino-fenyl) ethaanderivaten, werkwijze ter bereiding van farma- ceutische preparaten, die deze verbindingen bevatten en verkregen farmaceutische preparaten. | |
| NL7610761A (nl) | Werkwijze voor de bereiding van prostaglandinen en van preparaten die ze bevatten. | |
| NL154510B (nl) | Werkwijze voor de bereiding van rifamycine-derivaten en van preparaten die ze bevatten. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| V4 | Discontinued because of reaching the maximum lifetime of a patent |